Studies - Celebre Pro Medic

Clinical Studies

Treatment with human umbilical cord-1 derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo-controlled phase 2 trial

July 4, 2022

1️⃣ Treatment of severe Corona Virus Disease 2019 (COVID-19) is challenging. We performed a phase 2 trial to assess the

HUMAN IPS-DERIVED PRE-EPICARDIAL CELLS DIRECT CARDIOMYOCYTE AGGREGATION EXPANSION AND ORGANIZATION IN VITRO

July 4, 2022

1️⃣ Directed CM differentiation of human-induced pluripotent stem cells (hiPSCs) employs systematic biochemical treatments to streamline definitive stages of cardiac

Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial

July 1, 2022

1️⃣ Although conventional treatments show modest benefits, pilot and phase I/II trials with bone marrow (BM) and adipose-derived (AD) mesenchymal

Covid-19 Patient treated by Human Umbilical Cord Mesenchymal Stem Cells

July 1, 2022

1️⃣ The human umbilical cord mesenchymal stem cells (hUCMSCs) have shown very good capability to modulate immune response and repair